Biosimilars
Companies working to replicate original biologic drugs and distribute them globally at lower prices.
−0.24% today·7 stocks
Stocks
By market cap · 7 stocks
- 1
Novartis (ADR)NVSDeveloper of focused innovative medicines$292.35B−0.54% - 2
PfizerPFEDeveloper of Eliquis, Prevnar and cancer medicines$159.36B−0.21% - 3
GSK (ADR)GSKDeveloper of Shingrix, Nucala, and Trelegy$101.82B+1.11% - 4
ViatrisVTRSGlobal maker of established brands and generics$19.03B−3.26% - 5
AlvotechALVOIntegrated developer and manufacturer of biosimilars$1.67B+1.13% - 6
Coherus OncologyCHRSLOQTORZI-centered immuno-oncology developer$217.8M−3.42% - 7
AEON BiopharmaAEONTherapeutic Botox biosimilar developer$13.9M+5.07%